ArticleFrontiers in pharmacology2025
Association between acetaminophen use and 30-day mortality in critically ill patients with pulmonary embolism: a retrospective cohort study using the MIMIC-IV database.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Pulmonary embolism (PE) has high mortality rates among critically ill patients. While acetaminophen shows potential therapeutic effects in critical illness, its impact on ICU patients with PE remains unclear. This study evaluated the association between acetaminophen use and 30-day mortality in ICU patients with PE. Patients and methods: A retrospective cohort study was conducted using the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Adult patients admitted to the ICU with confirmed PE between 2008 and 2022 were included. The primary exposure was acetaminophen use during the ICU stay, and the primary outcome was 30-day all-cause mortality. To control for confounding factors, propensity score matching (PSM) was applied, along with inverse probability weighting, propensity score adjustment, and E-value analysis to assess result robustness. Causal mediation analysis was performed to evaluate the mediating role of body temperature. Results: Among 1,983 eligible patients, 1,355 received acetaminophen and 628 did not. After propensity score matching (599 pairs), acetaminophen use was associated with a 31% reduction in 30-day mortality risk (HR 0.69, 95% CI: 0.56-0.85, P = 0.001). This protective effect was more pronounced in patients requiring mechanical ventilation (HR 0.53, 95% CI: 0.34-0.82) and vasopressor support (HR 0.52, 95% CI: 0.32-0.83). Enhanced benefits were also observed in younger patients (<65 years, HR 0.52, 95% CI: 0.31-0.85). Multiple sensitivity analyses yielded consistent results, with E-values ranging from 2.03 to 2.26, suggesting robust resistance to unmeasured confounding. Causal mediation analysis revealed that 54.2% (95% CI: 25.6%-187.5%, P = 0.014) of acetaminophen's apparent protective effect was mediated through body temperature regulation during hospitalization. Conclusion: acetaminophen use was associated with reduced 30-day mortality in critically ill patients with PE, with temperature control appearing to play a potential mediating role. These preliminary findings provide hypothesis-generating evidence that warrants validation in prospective randomized controlled trials before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.